- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,982 public trials
1,832 recruiting studies
Lymphatic Diseases trial results
NCT00773149
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Saint Antoine Hospital, Hematology Unit Paris, France
NCT00552799
- Conditions
- Cellulitis, Cellulitis/Erysipelas of the Leg, Connective Tissue Diseases, +10 more
- Locations
-
- South Infirmary-Victoria University Hospital Cork, Ireland
- Queens Medical Centre Nottingham, Nottinghamshire, United Kingdom
- Aberdeen Royal Infirmary Aberdeen, United Kingdom
- Amersham Hospital Amersham, United Kingdom
NCT00421213
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
- Locations
-
- Miami, Florida, United States
- Chicago, Illinois, United States
- Bethesda, Maryland, United States
- Fargo, North Dakota, United States
NCT00592046
- Conditions
- Acute Leukemia, Anemia, Anemia, Refractory, +31 more
- Locations
-
- Houston, Texas, United States
NCT00732316
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
- Locations
-
- Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea
NCT00816283
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
NCT00796731
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 250004 Créteil, France
- Sanofi-Aventis Investigational Site Number 250006 Lille, France
- Sanofi-Aventis Investigational Site Number 250001 Pierre-Bénite, France
- Sanofi-Aventis Investigational Site Number 250005 Rennes, France
Completed
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
NCT00051025
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Central Baptist Hospital Lexington, Kentucky, United States
- Hematology and Oncology Services Metairie, Louisiana, United States
NCT01639716
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Ondokuz Mayis University Medical School Samsun, Atakum, Turkey (Türkiye)